NCT05581589 2026-02-27
Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06764095 2026-02-12
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Mayo Clinic
Phase 4 Recruiting
NCT06263153 2025-12-17
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT06091124 2025-12-08
NEOBLAST
RenJi Hospital
Phase 2 Recruiting
NCT05312671 2025-06-29
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT06341400 2024-12-04
RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
Zhujiang Hospital
Phase 1/2 Recruiting
NCT05153694 2024-09-19
Infectious Complications After Cystectomy: A Prospective Observational Study
Ludwig-Maximilians - University of Munich
Recruiting
NCT06170177 2023-12-14
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
IRCCS San Raffaele
Recruiting
NCT04900558 2021-05-25
Robotic Radical Cystectomy Outcomes
University of Florence
Recruiting
NCT04588168 2020-10-19
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting